130 related articles for article (PubMed ID: 6130903)
1. Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
Parkinson A; Lasker J; Kramer MJ; Huang MT; Thomas PE; Ryan DE; Reik LM; Norman RL; Levin W; Conney AH
Drug Metab Dispos; 1982; 10(6):579-85. PubMed ID: 6130903
[TBL] [Abstract][Full Text] [Related]
2. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
Budris DM; Yim GK; Schnell RC
J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
[TBL] [Abstract][Full Text] [Related]
3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
4. Effect of p-amino-diphenyl ethers on hepatic microsomal cytochrome P450.
Jiang H; Xuan G
Pharmazie; 2003 Sep; 58(9):654-6. PubMed ID: 14531464
[TBL] [Abstract][Full Text] [Related]
5. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
Atal CK; Dubey RK; Singh J
J Pharmacol Exp Ther; 1985 Jan; 232(1):258-62. PubMed ID: 3917507
[TBL] [Abstract][Full Text] [Related]
6. Decrease in the activity of the drug-metabolizing enzymes of rat liver following the administration of tilorone hydrochloride.
Leeson GA; Biedenbach SA; Chan KY; Gibson JP; Wright GJ
Drug Metab Dispos; 1976; 4(3):232-8. PubMed ID: 6227
[TBL] [Abstract][Full Text] [Related]
7. Effect of tetrachlorophthalic anhydride on hepatic microsomal metabolism in rats and mice.
Ridley WP; Warren J; Nair RS
J Toxicol Environ Health; 1988; 24(2):217-27. PubMed ID: 3385798
[TBL] [Abstract][Full Text] [Related]
8. Depression of the hepatic cytochrome P-450 monooxygenase system by treatment of mice with the antineoplastic agent 5-azacytidine.
Gooderham NJ; Mannering GJ
Cancer Res; 1985 Apr; 45(4):1569-72. PubMed ID: 2579731
[TBL] [Abstract][Full Text] [Related]
9. Effects of interferon on drug metabolism.
Sonnenfeld G; Harned CL; Nerland DE
Tex Rep Biol Med; 1981-1982; 41():363-9. PubMed ID: 6817439
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
11. Influence of various purified interferons on effects of drugs in mice.
Moore JA; Marafino BJ; Stebbing N
Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):113-25. PubMed ID: 6189163
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice.
Armstrong SG; Renton KW
Mol Pharmacol; 1993 Apr; 43(4):542-7. PubMed ID: 8379989
[TBL] [Abstract][Full Text] [Related]
13. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
Brunda MJ; Rosenbaum D
Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
[TBL] [Abstract][Full Text] [Related]
14. Induction of xanthine oxidase and heme oxygenase and depression of liver drug metabolism by interferon: a study with different recombinant interferons.
Ghezzi P; Saccardo B; Bianchi M
J Interferon Res; 1986 Jun; 6(3):251-6. PubMed ID: 3018103
[TBL] [Abstract][Full Text] [Related]
15. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
Farrell GC; Gollan JL; Correia MA; Schmid R
J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
Edwards BS; Hawkins MJ; Borden EC
Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
[TBL] [Abstract][Full Text] [Related]
17. Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine.
Griffeth LK; Rosen GM; Rauckman EJ
Drug Metab Dispos; 1984; 12(5):582-7. PubMed ID: 6149908
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic exposure to cadmium on renal cytochrome P450-dependent monooxygenase system in rats.
Plewka A; Plewka D; Nowaczyk G; Brzóska MM; Kamiński M; Moniuszko-Jakoniuk J
Arch Toxicol; 2004 Apr; 78(4):194-200. PubMed ID: 14595535
[TBL] [Abstract][Full Text] [Related]
19. Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations.
Griffeth LK; Rosen GM; Rauckman EJ
Drug Metab Dispos; 1984; 12(5):588-95. PubMed ID: 6149909
[TBL] [Abstract][Full Text] [Related]
20. Doxapram inhibits the in vitro oxidation of hexobarbital.
Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):371-4. PubMed ID: 1719592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
